about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More
2.01
0.02
(1.01%)
101.9K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for VivoSim Labs Inc. is on 05 Aug 2025 for the purpose of Organovo Holdings Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
VivoSim Labs Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..